To Örebro University

oru.seÖrebro University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Preventing Parastomal Hernia After Ileal Conduit by the Use of a Prophylactic Mesh: A Randomised Study
Institution of Translational Medicine, Lund University, Malmö, Sweden; Department of Urology, Skåne University Hospital, Malmö, Sweden.
Institution of Translational Medicine, Lund University, Malmö, Sweden; Department of Urology, Skåne University Hospital, Malmö, Sweden; Department of Urology, Helsingborg County Hospital, Helsingborg, Sweden.
Department of Urology, Helsingborg County Hospital, Helsingborg, Sweden.
Institution of Translational Medicine, Lund University, Malmö, Sweden; Department of Urology, Skåne University Hospital, Malmö, Sweden.
Show others and affiliations
2020 (English)In: European Urology, ISSN 0302-2838, E-ISSN 1873-7560, Vol. 78, no 5, p. 757-763Article in journal (Refereed) Published
Abstract [en]

BACKGROUND: Parastomal hernia (PSH) after urinary diversion with ileal conduit is frequently a clinical problem.

OBJECTIVE: To investigate whether a prophylactic lightweight mesh in the sublay position can reduce the cumulative incidence of PSH after open cystectomy with ileal conduit.

DESIGN, SETTING, AND PARTICIPANTS: From 2012 to 2017, we randomised 242 patients 1:1 to conventional stoma construction (n = 124) or prophylactic mesh (n = 118) at three Swedish hospitals (ISRCTN 95093825).

OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: The primary endpoint was clinical PSH, and secondary endpoints were radiological PSH assessed in prone position with the stoma in the centre of a ring, parastomal bulging, and complications from the mesh.

RESULTS AND LIMITATIONS: Within 24 mo, 20/89 (23%) patients in the control arm and 10/92 (11%) in the intervention arm had developed a clinical PSH (p = 0.06) after a median follow-up of 3 yr, corresponding to a hazard ratio of 0.45 (confidence interval 0.24-0.86, p = 0.02) in the intervention arm. The proportions of radiological PSHs within 24 mo were 22/89 (25%) and 17/92 (19%) in the two study arms. During follow-up, five patients in the control arm and two in the intervention arm were operated for PSH. The median operating time was 50 min longer in patients receiving a mesh. No differences were noted in proportions of Clavien-Dindo complications at 90 d postoperatively or in complications related to the mesh during follow-up.

CONCLUSIONS: Prophylactic implantation of a lightweight mesh in the sublay position decreases the risk of PSH when constructing an ileal conduit without increasing the risk of complications related to the mesh. The median surgical time is prolonged by mesh implantation.

PATIENT SUMMARY: In this randomised report, we looked at the risk of parastomal hernia after cystectomy and urinary diversion with ileal conduit with or without the use of a prophylactic mesh. We conclude that such a prophylactic measure decreased the occurrence of parastomal hernias, with only a slight increase in operating time and no added risk of complications related to the mesh.

Place, publisher, year, edition, pages
Elsevier, 2020. Vol. 78, no 5, p. 757-763
Keywords [en]
Bladder cancer, Cystectomy, Ileal conduit, Parastomal hernia, Prophylactic mesh
National Category
Clinical Medicine Cancer and Oncology
Identifiers
URN: urn:nbn:se:oru:diva-85112DOI: 10.1016/j.eururo.2020.07.033ISI: 000579504100035PubMedID: 32800407Scopus ID: 2-s2.0-85089355855OAI: oai:DiVA.org:oru-85112DiVA, id: diva2:1464557
Funder
Swedish Cancer Society, CAN 2017/278
Note

Funding Agencies:

Lund Medical Faculty (ALF)  

Skane University Hospital Research Funds  

Gyllenstierna Krapperup's Foundation  

Skane County Council's Research and Development Foundation  REGSKANE-821461

Cancer Research Fund at Malmo General Hospital  

Gösta Jonsson Research Foundation  

Foundation of Urological Research  

Bergqvist Foundation  

Stig and Ragna Gohrton Research Foundation  

Thelma Zoega Research Foundation  

Hillevi Fries Research Foundation 

Available from: 2020-09-07 Created: 2020-09-07 Last updated: 2025-02-18Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records

Jerlström, Tomas

Search in DiVA

By author/editor
Jerlström, Tomas
By organisation
School of Medical SciencesÖrebro University Hospital
In the same journal
European Urology
Clinical MedicineCancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 117 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf